Additional long-term (24 h) cytotoxicity assays demonstrated similar or superior killing of all tumor targets by KIR+ UCB56 NK cells compared to the KIR−UCB34 NK cells (Figure 3B). Here, KIR3DL1 is linked to neoplasm.